efficacy and safety of propacetamol for pain management after surgery of breast cancer

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000807

Enrollment

120

Registered

2013-07-24

Start date

2013-07-10

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : propacetamol 1 or 2 mg intravenous bolus administration

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: planned partial mastectomy

Exclusion criteria

Exclusion criteria: previous side effects history of acetaminophen abnormal liver function

Design outcomes

Primary

Measure	Time frame
pain score	—

Secondary

Measure	Time frame
satisfactory score	—

Countries

Korea, Republic of

Contacts

Public ContactHee-Soo KIM

Seoul National University Hospital

heejeong895@gmail.com+82-2-2072-3659

Outcome results